Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Trial Evaluating the Efficacy and Safety of Lenvatinib, Nivolumab, and Chemotherapy in Metastatic Gastric Cancer With Malignant Ascites.

NCT07149090 is registered in ClinicalTrials.gov with Asan Medical Center as lead sponsor.

NCT NCT07149090
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07149090 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Trial Evaluating the Efficacy and Safety of Lenvatinib, Nivolumab, and Chemotherapy in Metastatic Gastric Cancer With Malignant Ascites.
Lead sponsor
Asan Medical Center
Phase
Phase 1/2
Overall status
Recruiting
Start date
November 11, 2025
Completion date
July 30, 2027
Enrollment
61 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer, gastric cancer adenocarcinoma metastatic, stomach neoplasm